Blandini, F., et al., Movement Disorders, Princ. Neural. Aging, 1997, 441-453. |
Koller, W.C., et al., Pharmacologic Treatment of Essential Tremor, Neurology, 2000, 54(11, Suppl. 4), S30-S38. |
Gasser, T., et al., Genetics of Parkinson's Disease and Other Movement Disorders, Neurogenetics, 2000, 351-372. |
Collado-Seidel, V., et al., Aetiology and Treatment of Restless Legs Syndrome, CNS Drugs, 1999, 12(1), 9-20. |
Bucher, S.F., et al., Cerebral Generators Involved in the Pathogenesis of the Restless Legs Syndrome, Annals of Neurology, 1997, 41(5), 639-645. |
Kanazawa, I., Extrapyramidal Tract Symptoms in Degenerative Diseases. Involuntary Movement in Degenerative Diseases, Huntington's Disease, Chorea-Acanthocytosis and Benign Hereditary Chorea, Saishin Naikagaku Taikei, 1997, 68, 156-163 (with English translations). |
Scheidt, C.E., Psychosomatic Aspects of Idiopathic Spasmodic Torticollis. Results of a Multicenter Study. Psychotherapie, Psychosomatik, Medizinische Psychologies, 1998, 48(1), 1-12, (with English translations). |
Caligiuri, M.P., Antipsychotic-induced Movement Disorders in the Elderly; Epidemiology and Treatment Recommentations, Drugs Aging, 2000, 17(5), 363-384. |
Poewe, W., What is New in Movement Disorders, Wien, Klin. Wochenschr., 1999, 111(17), 664-671. |
Klein, C., et al., Evaluation of the Role of the D2 Dopamine Receptor in Myoclonus Dystonia, Ann. Neurol., 2000, 47(3), 369-373. |
Ettore, B., The Use of Anticonvulsants in Neurological Conditions other than Epilepsy: A Review of the Evidence from Randomized Controlled Trials, CNS Drugs, 1999, 11(1), 61-82. |
Tanner, C.M., Epidemiology of Movement Disorders, In: Anderson DW editor. Neuroepidemiology, CRC Press, 1991, 193-216. |
Iwata, S., et al., Effects of Beta-adrenergic Blockers on Drug-induced Tremors, Biochem. Behav., 1993, 44(3), 611-613. |
Galvez-Jimenez, N. and Hargreave, M., Topiramate and Esstntial Tremor, Ann. Neurol., 2000, 47(6), 837-838. |
Gorman, W.P., et al., A Comparison of Primidone, Propranolol in Essential Tremor, Using Quantitative Analysis, J. Neurol. Neurosurg. Psychiatry, 1986, 49, 64-68. |
Gironell, A., et al., A Randomized Placebo-controlled Comparative Trial of Gabapentin and Propranolol in Essential Tremor, Arch. Neurol., 1999, 56, 475-480. |
Magnus, L., Nonepileptic Uses of Gabapentin, Epilepsia, 1999, 40(Suppl. 6), S66-72; 837-838. |
Adler, C.H., Treatment of Restless Legs Syndrome with Gabapentin, Clin. Neuropharmacol., 1997, 20(2), 148-151. |
Merren, M.D., Gabapentin for Treatment of Pain and Tremor: A Large Case Series, South Med. J., 1998, Aug., 91 (8) 739-744. |
Wetter, T.C., Pollmacher, T., Restless Legs and Periodic Leg Movements in Sleep Syndromes, J. Neurol., 1997, Apr., 244 (4 Supp 1), S37-45). |
PCT International Search Report PCT/US02/05542 dated Jul. 9, 2002. |
U.S. patent application Ser. No. 09/906,251, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/081,713, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/081,766, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/081,606, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/081,761, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/192,973, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/081,943, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/193,600, Ortho-McNeil Pharmaceutical, Inc. |
U.S. patent application Ser. No. 10/081,764, Ortho-McNeil Pharmaceutical, Inc. |